Deutsche Bank’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,962
Closed -$619K 3707
2023
Q4
$619K Buy
+9,962
New +$248K ﹤0.01% 2270

Deutsche Bank's RYZB Position: Q1 2024 in Review

Deutsche Bank sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 9,962 shares — an estimated $619K sold.

Deutsche Bank first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $619K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Deutsche Bank reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 9,962 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $619K.
  • Deutsche Bank first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Deutsche Bank's RayzeBio, Inc. Common Stock position peaked at $619K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.